Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

METHYLATROPINE BROMIDE CRS (30 MG)

METHYLATROPINE BROMIDE CRS (30 MG)

2870-71-5

DISCOVER
Milbemycine

Milbemycine

51596-11-3

DISCOVER
METHYL 2-(4- CHLOROPHENOXY)-2- METHYLPROPIONATE CRS (0.5 ML)

METHYL 2-(4- CHLOROPHENOXY)-2- METHYLPROPIONATE CRS (0.5 ML)

NA

DISCOVER
Mercaptopurine

Mercaptopurine

50-44-2

DISCOVER
METHYLDOPA CRS (50 MG)

METHYLDOPA CRS (50 MG)

41372-08-1

DISCOVER
Mestranol

Mestranol

72-33-3

DISCOVER
Methylene chloride CRS, 1.5mL

Methylene chloride CRS, 1.5mL

75-09-02

DISCOVER
METHYL 12-HYDROXYSTEARATE CRS(110 MG)

METHYL 12-HYDROXYSTEARATE CRS(110 MG)

141-23-1

DISCOVER
METHYLNITROSOINDOLINE CRS (110 MG)

METHYLNITROSOINDOLINE CRS (110 MG)

85440-79-5

DISCOVER
Mefenamic acid

Mefenamic acid

61-68-7

DISCOVER
METHYL PARAHYDROXYBENZOATE CRS (150 MG)

METHYL PARAHYDROXYBENZOATE CRS (150 MG)

99-76-3

DISCOVER
METHYLPHENOBARBITAL CRS - * PSY (500 MG)

METHYLPHENOBARBITAL CRS - * PSY (500 MG)

115-38-8

DISCOVER